US Patent Issued to Novo Nordisk on Dec. 23 for "Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS6) expression" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,503,701, issued on Dec. 23, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).

"Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS6) expression" was invented by Anna Linda Blois (Sudbury, Mass.), Christina Marie Priest (Lexington, Mass.), Jihye Park (Cambridge, Mass.) and Henryk Dudek (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Oligonucleotides are provided herein that inhibit TMPRSS6 expression. Also provided are compositions including the same and uses thereof, particularly uses relating to treating diseases, disorders and/or conditions associated with hepcidin deficiency or suppression."

The patent...